U.S. Health and Human Services Secretary Robert F. Kennedy Jr. is facing backlash after firing all 17 members of the CDC’s Advisory Committee on Immunization Practices (ACIP) and replacing them with eight new members, several of whom have histories of vaccine skepticism. The move has raised concerns among public health experts and lawmakers, including Senator Bill Cassidy, a Republican and physician from Louisiana who chairs the Senate Health Committee.
Cassidy had previously supported Kennedy's confirmation after receiving assurances that the ACIP structure would remain intact. “If confirmed, he will maintain the CDC’s ACIP without changes,” Cassidy had said during a Senate floor speech. However, Kennedy now says he only promised to let Cassidy choose one candidate for the panel, a pledge he intends to honor.
During a Fox News interview, Kennedy denied violating any agreement. “I told Senator Cassidy I would allow him to put one of his candidates on, which we’re going to do,” he stated. Cassidy’s office later clarified the commitment was about maintaining the ACIP process, not preventing staff changes.
Kennedy defended his decision, citing alleged conflicts of interest among the previous members, though he offered no specific evidence. His reshuffle has drawn sharp criticism from the American Medical Association, which called for an investigation and a reversal of the firings. Critics argue that stacking the panel with vaccine skeptics could undermine public trust in immunization policy.
The ACIP plays a key role in advising the CDC on who should receive vaccines after FDA approval. The controversy has intensified scrutiny of Kennedy’s long-standing views on vaccines, which often contradict mainstream medical consensus. With political and public health stakes high, the debate over ACIP’s direction is far from over.


25 Democratic-Led States Sue Trump Administration Over New Global Tariffs
New Zealand MMP Electoral System Faces Fresh Referendum Debate
US-Backed Venezuela Government, Opposition Talks Begin
CDC Expands Ebola Screening Efforts at U.S. Entry Points Amid Congo and Uganda Outbreak
US Supreme Court Lets $655.5 Million Judgment Against Palestinian Authorities Stand During Appeal
US Plans Kenya Ebola Quarantine Facility Amid Congo Outbreak
TrumpRx Expands Discount Drug Access With 600 Generic Medications
US Continues Ukraine Patriot Missile Production Talks Despite Trump’s Concerns
SEC Moves to Dismiss Insider Trading Case Against Trump-Pardoned Terren Peizer
AstraZeneca Q2 Earnings Beat Forecasts as Oncology Growth Supports 2026 Outlook
Ukraine Agrees to Protect Kazakhstan Oil Exports via Black Sea
Trump Orders Warning Signs Outside Smithsonian Museum Over ‘Anti-American’ Exhibits
FDA Investigates New Cyclospora Outbreak as U.S. Cases Continue to Rise
Canada, US Hold Constructive Trade Talks as Tariff Negotiations Continue
GSK Reportedly Nears $9 Billion Acquisition of Cancer Drug Developer Nuvalent
California ICE Detention Center Found to Have Inadequate Medical Care, Court Monitor Says
Appeals Court Rejects Trump Bid to Reinstate $100,000 H-1B Visa Fee 



